Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · Real-Time Price · USD
8.93
-0.24 (-2.62%)
May 13, 2025, 4:00 PM - Market closed
CNCR Holdings List
As of May 9, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | SMMT | Summit Therapeutics Inc. | 2.20% |
2 | IPHA | Innate Pharma S.A. | 2.18% |
3 | FATE | Fate Therapeutics, Inc. | 1.99% |
4 | BPMC | Blueprint Medicines Corporation | 1.95% |
5 | RVMD | Revolution Medicines, Inc. | 1.91% |
6 | TSVT | 2seventy bio, Inc. | 1.86% |
7 | SDGR | Schrödinger, Inc. | 1.86% |
8 | NUVB | Nuvation Bio Inc. | 1.85% |
9 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.84% |
10 | EXEL | Exelixis, Inc. | 1.80% |
11 | ERAS | Erasca, Inc. | 1.76% |
12 | IMCR | Immunocore Holdings plc | 1.75% |
13 | TYRA | Tyra Biosciences, Inc. | 1.73% |
14 | HCM | HUTCHMED (China) Limited | 1.73% |
15 | STRO | Sutro Biopharma, Inc. | 1.73% |
16 | GMAB | Genmab A/S | 1.72% |
17 | SWTX | SpringWorks Therapeutics, Inc. | 1.71% |
18 | BNTX | BioNTech SE | 1.70% |
19 | FHTX | Foghorn Therapeutics Inc. | 1.69% |
20 | IDYA | IDEAYA Biosciences, Inc. | 1.68% |
21 | NUVL | Nuvalent, Inc. | 1.67% |
22 | ITOS | iTeos Therapeutics, Inc. | 1.67% |
23 | RCUS | Arcus Biosciences, Inc. | 1.67% |
24 | ZYME | Zymeworks Inc. | 1.66% |
25 | ELVN | Enliven Therapeutics, Inc. | 1.62% |
26 | KYMR | Kymera Therapeutics, Inc. | 1.61% |
27 | MRUS | Merus N.V. | 1.60% |
28 | RLAY | Relay Therapeutics, Inc. | 1.58% |
29 | IMTX | Immatics N.V. | 1.57% |
30 | LEGN | Legend Biotech Corporation | 1.55% |
31 | BCYC | Bicycle Therapeutics plc | 1.54% |
32 | CGEM | Cullinan Therapeutics, Inc. | 1.54% |
33 | SNDX | Syndax Pharmaceuticals, Inc. | 1.51% |
34 | YMAB | Y-mAbs Therapeutics, Inc. | 1.51% |
35 | JANX | Janux Therapeutics, Inc. | 1.50% |
36 | INBX | Inhibrx Biosciences, Inc. | 1.48% |
37 | MRK | Merck & Co., Inc. | 1.48% |
38 | GNLX | Genelux Corporation | 1.47% |
39 | ACLX | Arcellx, Inc. | 1.46% |
40 | KURA | Kura Oncology, Inc. | 1.46% |
41 | REGN | Regeneron Pharmaceuticals, Inc. | 1.44% |
42 | CMPX | Compass Therapeutics, Inc. | 1.43% |
43 | BMY | Bristol-Myers Squibb Company | 1.43% |
44 | LYEL | Lyell Immunopharma, Inc. | 1.43% |
45 | ARVN | Arvinas, Inc. | 1.40% |
46 | CRBU | Caribou Biosciences, Inc. | 1.40% |
47 | PGEN | Precigen, Inc. | 1.38% |
48 | DAWN | Day One Biopharmaceuticals, Inc. | 1.37% |
49 | AUTL | Autolus Therapeutics plc | 1.34% |
50 | IBRX | ImmunityBio, Inc. | 1.31% |
As of May 9, 2025